Researchers are exploring next-generation antimicrobials to target the mechanisms of infection, including those that can combat antibiotic-resistant bacteria. Various approaches are being investigated, such as antimicrobial peptides, antibody-antibiotic conjugates, and bacterial secondary metabolites. The development of these new antimicrobials may offer opportunities to address the challenges posed by multidrug-resistant bacterial infections.